These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 30088269)

  • 1. The use of charcoal filters in malignant hyperthermia: have they found their place?
    Bilmen JG; Hopkins PM
    Anaesthesia; 2019 Jan; 74(1):13-16. PubMed ID: 30088269
    [No Abstract]   [Full Text] [Related]  

  • 2. Manufacturer's response to Bilmen and Gillies' manuscript entitled "clarifying the role of activated charcoal filters in preparing an anaesthetic workstation for malignant hyperthermia-susceptible patients".
    Orr J; Sakata D
    Anaesth Intensive Care; 2014 Nov; 42(6):801-2. PubMed ID: 25342416
    [No Abstract]   [Full Text] [Related]  

  • 3. Clarifying the role of activated charcoal filters in preparing an anaesthetic workstation for malignant hyperthermia-susceptible patients.
    Bilmen JG; Gillies RI
    Anaesth Intensive Care; 2014 Jan; 42(1):51-8. PubMed ID: 24471664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation of anaesthesia workstation for trigger-free anaesthesia: An observational laboratory study.
    Thoben C; Dennhardt N; Krauß T; Sümpelmann R; Zimmermann S; Rüffert H; Heiderich S
    Eur J Anaesthesiol; 2019 Nov; 36(11):851-856. PubMed ID: 31580288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activated charcoal effectively removes inhaled anesthetics from modern anesthesia machines.
    Birgenheier N; Stoker R; Westenskow D; Orr J
    Anesth Analg; 2011 Jun; 112(6):1363-70. PubMed ID: 21543783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Residual volatile anesthetics after workstation preparation and activated charcoal filtration.
    Müller-Wirtz LM; Godsch C; Sessler DI; Volk T; Kreuer S; Hüppe T
    Acta Anaesthesiol Scand; 2020 Jul; 64(6):759-765. PubMed ID: 32153012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of activated charcoal filters in anaesthetic circuits in suspected malignant hyperthermia.
    Bickmore EG; Aziz E; Nathanson M
    Anaesthesia; 2017 Nov; 72(11):1423-1424. PubMed ID: 29047129
    [No Abstract]   [Full Text] [Related]  

  • 8. Efficacy of Malignant Hyperthermia Association of the United States-Recommended Methods of Preparation for Malignant Hyperthermia-Susceptible Patients Using Dräger Zeus Anesthesia Workstations and Associated Costs.
    Neira VM; Al Madhoun W; Ghaffari K; Barrowman N; Berrigan P; Splinter W
    Anesth Analg; 2019 Jul; 129(1):74-83. PubMed ID: 29847377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malignant hyperthermia and charcoal absorbent: too hot to handle.
    Block FE
    Anesth Analg; 2011 Jun; 112(6):1270-1. PubMed ID: 21613194
    [No Abstract]   [Full Text] [Related]  

  • 10. Activated charcoal adsorption of volatile anesthetic agents for anesthesia machine preparation of malignant hyperthermia susceptible patients.
    Martin JW; Welliver MD
    AANA J; 2013 Jun; 81(3):169-71. PubMed ID: 23923663
    [No Abstract]   [Full Text] [Related]  

  • 11. [An activated charcoal filter for eliminating volatile anesthetics. A contribution to the management of malignant hyperthermia].
    Jantzen JP; Eck J; Kleemann PP
    Anaesthesist; 1989 Nov; 38(11):639-41. PubMed ID: 2635839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation of Dräger Atlan A350 and General Electric Healthcare Carestation 650 anesthesia workstations for malignant hyperthermia susceptible patients.
    Heiderich S; Thoben C; Dennhardt N; Krauß T; Sümpelmann R; Zimmermann S; Reitz M; Rüffert H
    BMC Anesthesiol; 2021 Dec; 21(1):315. PubMed ID: 34903173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignant hyperthermia: removal of volatile anesthetic agents from the breathing circuit using activated charcoal.
    Greene ER
    Anesthesiology; 1986 Aug; 65(2):240-1. PubMed ID: 3740531
    [No Abstract]   [Full Text] [Related]  

  • 14. Consensus guidelines on perioperative management of malignant hyperthermia suspected or susceptible patients from the European Malignant Hyperthermia Group.
    Rüffert H; Bastian B; Bendixen D; Girard T; Heiderich S; Hellblom A; Hopkins PM; Johannsen S; Snoeck MM; Urwyler A; Glahn KPE;
    Br J Anaesth; 2021 Jan; 126(1):120-130. PubMed ID: 33131754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response by the authors, reflection of volatile anesthetic by the vapor-clean filter.
    Müller-Wirtz LM; Meiser A; Kermad A; Godsch C; Sessler DI; Volk T; Kreuer S; Hüppe T
    Acta Anaesthesiol Scand; 2020 Oct; 64(9):1383-1384. PubMed ID: 32686079
    [No Abstract]   [Full Text] [Related]  

  • 16. Anesthesia for patients with a history of malignant hyperthermia.
    Wappler F
    Curr Opin Anaesthesiol; 2010 Jun; 23(3):417-22. PubMed ID: 20173632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation of the Drager Fabius CE and Drager Zeus anaesthetic machines for patients susceptible to malignant hyperthermia.
    Shanahan H; O'Donoghue R; O'Kelly P; Synnott A; O'Rourke J
    Eur J Anaesthesiol; 2012 May; 29(5):229-34. PubMed ID: 22388705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Anesthesia in a case of mitochondrial myopathy].
    Torres MD; Fernández-Esplá A; Baeza C; Torres C; Soler G
    Rev Esp Anestesiol Reanim; 1996 Mar; 43(3):114-5. PubMed ID: 8848637
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparing charcoal and zeolite reflection filters for volatile anaesthetics: A laboratory evaluation.
    Sturesson LW; Frennström JO; Ilardi M; Reinstrup P
    Eur J Anaesthesiol; 2015 Aug; 32(8):521-6. PubMed ID: 25387299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ambulatory surgery and malignant hyperthermia.
    Brandom BW
    Curr Opin Anaesthesiol; 2009 Dec; 22(6):744-7. PubMed ID: 19812484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.